CN Patent

CN115364049B — 一种月桂酰阿立哌唑混悬剂的制备方法

Assigned to Suzhou Enhua Biomedical Technology Co ltd · Expires 2026-04-10 · 0y expired

What this patent protects

本发明属于医药技术领域，具体涉及一种月桂酰阿立哌唑混悬剂的制备方法，包括以下步骤：(a)通过将月桂酰阿立哌唑与第一表面活性剂、水合并得到母液；(b)将所述母液均质化以形成D90在10～25μm之间的中间体混悬液；(c)加热所述中间体混悬液；(d)当步骤(c)得到的中间体混悬液冷却至室温时，与含第二表面活性剂的备用溶液合并得到月桂酰阿立哌唑混悬剂。

USPTO Abstract

本发明属于医药技术领域，具体涉及一种月桂酰阿立哌唑混悬剂的制备方法，包括以下步骤：(a)通过将月桂酰阿立哌唑与第一表面活性剂、水合并得到母液；(b)将所述母液均质化以形成D90在10～25μm之间的中间体混悬液；(c)加热所述中间体混悬液；(d)当步骤(c)得到的中间体混悬液冷却至室温时，与含第二表面活性剂的备用溶液合并得到月桂酰阿立哌唑混悬剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN115364049B
Jurisdiction
CN
Classification
—
Expires
2026-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Enhua Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.